TMPRSS2 and posterior cortical atrophy: Using our targeted RNA CaptureSeq method, we validated the RT‐PCR screening approach confirming TMPRSS2‐ERG status for the 12 fusion positive and 12 randomly selected early‐onset (range 44 to 62 years) fusion negative PCa cases.